For the Quarter Ending March 2026
Acebutolol Prices in North America
- In United States, the Acebutolol Price Index rose quarter-over-quarter in Q1 2026, driven by elevated chemical production costs.
- The Acebutolol Production Cost Trend increased in March 2026 as producer prices rose 4.0 percent year-over-year.
- Consumer prices increased 3.3 percent in March 2026, elevating transportation expenses for the Acebutolol Price Index.
- The Acebutolol Demand Outlook strengthened in March 2026, supported by a 4.0 percent retail sales growth.
- Unemployment at 4.3 percent and consumer confidence at 91.8 sustained Acebutolol prescription fulfillment in March 2026.
- The Manufacturing Index expanded while industrial production grew 0.7 percent in March 2026, ensuring Acebutolol synthesis.
- Propylene and ammonia feedstock costs strengthened in Q1 2026, elevating baseline synthesis expenses for domestic Acebutolol.
- Active Pharmaceutical Ingredient synthesis demand strengthened in Q1 2026, driving isopropylamine precursor procurement for Acebutolol production.
- United States import competition for epichlorohydrin intensified in Q1 2026, altering the Acebutolol Price Forecast trajectory.
Why did the price of Acebutolol change in March 2026 in North America?
- Propylene and chlorine feedstock costs strengthened the baseline synthesis expenses for Acebutolol during Q1 2026.
- Producer prices increased in March 2026, passing elevated manufacturing costs directly to United States buyers.
- Active Pharmaceutical Ingredient synthesis demand expanded in Q1 2026, supporting upward Acebutolol market pricing pressure.
Acebutolol Prices in APAC
- In China, the Acebutolol Price Index rose quarter-over-quarter in Q1 2026, driven by escalating upstream production costs.
- The Acebutolol Production Cost Trend increased during March 2026 alongside a 0.5% YoY PPI rise.
- The Acebutolol Demand Outlook remained mixed in March 2026, balancing 1.0% CPI and 1.7% retail sales growth.
- Consumer confidence hit 91.6 in February 2026, while 5.4% unemployment in March 2026 constrained domestic consumption.
- Industrial production grew 5.7% YoY and the manufacturing index expanded in March 2026, ensuring abundant supply.
- Crude oil and natural gas prices surged in March 2026, elevating operational expenses for pharmaceutical manufacturers.
- Global demand for Chinese active pharmaceutical ingredients strengthened in Q1 2026, boosting export order execution.
- India imposed anti-dumping duties on isopropylamine imports from China in February 2026, altering regional trade dynamics.
- The Acebutolol Price Forecast indicated upward pressure in Q1 2026 as producers focused on backlog orders.
Why did the price of Acebutolol change in March 2026 in APAC?
- Phenol value chain costs and upstream chemical raw material expenses rose sharply during March 2026.
- Domestic producers focused heavily on fulfilling backlog orders, tightening available spot inventories in Q1 2026.
- Pharmaceutical manufacturing value added accelerated in Jan-Feb 2026, boosting overall demand for active pharmaceutical ingredients.
Acebutolol Prices in Europe
- In Germany, the Acebutolol Price Index fell quarter-over-quarter in Q1 2026, driven by weakened epichlorohydrin feedstock costs.
- In March 2026, consumer inflation rose 2.7% year-over-year, while producer prices declined 0.2%, easing upstream synthesis costs.
- Industrial production remained flat at 0.0% in February 2026, whereas retail sales grew 0.7%, supporting pharmacy spending.
- The unemployment rate held at 4.2% in February 2026, despite consumer confidence hitting -24.7 in March 2026.
- The Manufacturing Index expanded in March 2026, but the Acebutolol Demand Outlook weakened as pharmaceutical production plummeted in January 2026.
- The Acebutolol Production Cost Trend diverged in Q1 2026, as upstream propylene and naphtha feedstock costs escalated.
- European epichlorohydrin inventories stabilized in March 2026, as inbound shipments and competitive imports maintained comfortable regional supply.
- The Acebutolol Price Forecast remained subdued in March 2026, reflecting softened procurement activity and adequate regional feedstock availability.
Why did the price of Acebutolol change in March 2026 in Europe?
- European costs for epichlorohydrin, a key Acebutolol feedstock, weakened moderately during the Q1 2026 period.
- Competitively priced import cargoes intensified downward pressure on regional European epichlorohydrin markets in March 2026.
- German pharmaceutical production for active ingredients like Acebutolol plummeted significantly during the January 2026 timeframe.
For the Quarter Ending December 2025
Acebutolol Prices in North America
- In United States, Acebutolol Price Index rose in Q4 2025, driven by elevated raw material costs and inflation.
- Acebutolol production costs increased in Q4 2025, influenced by a 3.0% year-over-year PPI rise in November 2025.
- Demand for Acebutolol remained stable in Q4 2025, supported by pharmaceutical optimism and consistent novel drug approvals.
- Acebutolol prices were supported in Q4 2025 by persistent inflation, despite softening natural gas spot prices in October 2025.
- Manufacturing output declined in Q4 2025, despite a slight December rise, impacting Acebutolol's broader supply chain.
- Trade and tariff volatility in Q4 2025 elevated Acebutolol raw material costs; intermediate goods inventory pared back in December 2025.
- Industrial production rose 2.0% year-over-year in December 2025, supporting Acebutolol's supply chain and overall market.
- A 4.4% unemployment rate in December 2025 and 3.3% year-over-year retail sales in November 2025 supported Acebutolol demand.
Why did the price of Acebutolol change in December 2025 in North America?
- Production costs rose from a 3.0% year-over-year PPI increase in November 2025.
- Raw material costs elevated in Q4 2025 due to tariffs and 2.7% YoY CPI in December 2025.
- Stable demand, supported by 4.4% unemployment and 89.1 consumer confidence in December 2025.
Acebutolol Prices in APAC
- In China, the Acebutolol Price Index declined quarter-over-quarter in Q4 2025, influenced by a -1.9% fall in producer prices in December 2025.
- Acebutolol production costs decreased in December 2025, driven by the -1.9% year-over-year decline in producer prices.
- Acebutolol demand outlook was mixed in Q4 2025, with manufacturing market demand improving in November and December 2025.
- Weak consumer spending, with retail sales growing 0.9% year-over-year in December 2025, impacted overall demand.
- The Manufacturing Index contracted in October and November 2025, then expanded in December 2025.
- Industrial production grew by 5.2% year-over-year in December 2025, indicating a robust manufacturing sector.
- Inventories of main raw materials declined in October 2025, then stabilized in November 2025.
- China's overall exports retained strength in Q4 2025, supporting Acebutolol trade.
- Cooled consumer confidence in Q4 2025 and 5.1% unemployment in December 2025 suggested cautious spending.
Why did the price of Acebutolol change in December 2025 in APAC?
- Producer prices declined by -1.9% year-over-year in December 2025, directly reducing Acebutolol production costs.
- Weak consumer spending (retail sales up 0.9% YoY in December 2025) and cooled consumer confidence dampened demand.
- Manufacturing market demand improved in December 2025, but overall economic caution limited price upside.
Acebutolol Prices in Europe
- Acebutolol Price Index faced downward pressure in Germany, reflecting a contracting Manufacturing Index in December 2025.
- Acebutolol production costs declined in December 2025, with the Producer Price Index (PPI) decreasing 2.5% year-over-year.
- Moderate pharmaceutical market growth in 2025 supported Acebutolol demand, despite a 6.2% unemployment rate in December 2025.
- High energy and carbon costs in 2025 challenged Acebutolol production, despite a 0.8% industrial production rise in October 2025.
- Weak domestic and export orders in October 2025 contributed to elevated Acebutolol inventory levels in the German chemical industry.
- Increased international competitive pressure and global overcapacity impacted Acebutolol trade dynamics in October 2025.
- Negative consumer confidence at -17.5 in December 2025 indirectly influenced healthcare spending and Acebutolol demand.
- Acebutolol Price Forecast suggests continued pressure from high energy costs and weak chemical industry business climate in October 2025.
Why did the price of Acebutolol change in December 2025 in Europe?
- Producer Price Index (PPI) declined 2.5% year-over-year in December 2025, reducing Acebutolol production costs.
- Weak export orders and increased international competition in October 2025 pressured Acebutolol prices downward.
- A contracting Manufacturing Index in December 2025 signaled industrial slowdown, impacting Acebutolol market sentiment.
For the Quarter Ending September 2025
Acebutolol Prices in North America
- In the United States, the Acebutolol Price Index rose quarter-over-quarter in Q3 2025, due to rising input costs.
- Acebutolol production costs increased in Q3 2025, driven by a 2.6% rise in PPI in August 2025.
- Natural gas feedstock costs strengthened significantly in Q3 2025, raising manufacturing expenses.
- The 3.0% CPI increase in September 2025 indicated general inflation, raising operational costs.
- Demand for Acebutolol was supported by continued upward healthcare spending in 2025.
- Retail sales surged 5.42% in September 2025, suggesting consumer economic health.
- A 0.1% industrial production growth in September 2025 indicated sluggish activity.
- The unemployment rate of 4.3% in September 2025 remained moderate, impacting patient access.
- Consumer confidence declined to 94.2 in September 2025, indicating softening economic sentiment.
- US chemical production contracted in Q3 2025, tightening inventories and weakening foreign orders.
Why did the price of Acebutolol change in September 2025 in North America?
- Production costs rose from a 2.6% PPI increase in August 2025 and strengthened natural gas prices.
- Demand was supported by continued upward healthcare spending in 2025, despite weakening chemical markets.
- Tightening finished goods inventories and contracted US chemical production contributed to price pressure.
Acebutolol Prices in APAC
- In China, Acebutolol Price Index declined in Q3 2025, influenced by deflationary pressures and lower input costs.
- Acebutolol production costs declined in Q3 2025, driven by a 2.3% fall in PPI and lower benzene prices.
- Demand outlook was mixed; industrial production rose 6.5%, retail sales grew 3.0% in September 2025.
- However, a contracting Manufacturing Index and cautious consumer confidence (89.6) tempered Acebutolol demand.
- The Acebutolol Price Index is forecast to remain under pressure due to persistent deflation and manufacturing sector contraction.
- Energy feedstock costs varied; natural gas production increased, and falling coal prices aided coal-based chemical producers in Q3 2025.
- Sulfuric acid inventories tightened by late Q3 2025, while China's total exports strengthened in September 2025.
- Policy changes included strict controls on new refining projects and phasing out aging units to address overcapacity.
Why did the price of Acebutolol change in September 2025 in APAC?
- Production costs fell due to 2.3% PPI decline and lower benzene spot prices in September 2025.
- Deflationary pressures from 0.3% CPI decline and contracting Manufacturing Index impacted demand in September 2025.
- Strengthening sulfuric acid export prices and tightening inventories provided upward cost pressure in September 2025.
Acebutolol Prices in Europe
- In Germany, the Acebutolol Price Index fell quarter-over-quarter in Q3 2025, driven by declining producer prices and reduced propylene feedstock costs.
- Acebutolol production costs faced mixed pressures in Q3 2025, with lower PPI but higher natural gas and electricity prices.
- Demand for Acebutolol remained steady in Q3 2025, supported by the pharmaceutical sector's resilience and an aging population.
- The Manufacturing Index trended Contracting in September 2025, signaling a slowdown in broader industrial activity.
- Germany's industrial production declined by 1.0% year-on-year in September 2025, impacting overall supply chain dynamics.
- Trade flows in Q3 2025 showed weakening German chemical exports and increased imports of goods, including pharmaceuticals.
- The Acebutolol Price Forecast is influenced by continued feedstock cost fluctuations and stable, inelastic pharmaceutical demand.
- Low unemployment at 3.9% in September 2025 supported healthcare funding, despite negative consumer confidence at -23.6.
Why did the price of Acebutolol change in September 2025 in Europe?
- Producer Price Index decreased by 1.7% in September 2025, lowering overall manufacturing input costs.
- Propylene feedstock costs continued to decline in Q3 2025, reducing Acebutolol production expenses.
- Despite rising energy costs, these direct input cost reductions exerted downward price pressure.
For the Quarter Ending December 2022
North America
- In the fourth quarter of 2022, the Acebutolol API market in North America experienced a fluctuating trend. Prices began to climb in Q4 2022 and continued to do so throughout the second month of the fourth quarter due to high manufacturing costs, numerous logistical issues, and rising inflation. The US inflation Soar to 8.2% in the month of October 2022.
- Additionally contributing to the price fluctuation were rising transportation costs and port congestion at the major ports. However, Prices begin to decline later in the month of December as a result of weaker inflation (the US inflation rate was 7%, down from 8.2% in October) and decreased end-user sector demand as the holiday season approaches. The Acebutolol API settlement price in December fell to USD 95336/MT CFR Los Angeles.
Asia
- The Asia Pacific Acebutolol API market saw a turbulent fourth quarter in 2022. It was witnessed that the prices rose considerably till the second month of the quarter due to increased end-user sector demand, several logistical challenges, and rising inflation. The Producer Price Index (PPI) grew by 0.9% while the Consumer Price Index in China increased by 2.8%, both of which had an impact on the market. The "Zero-Covid" policy in China has so far impacted investor confidence and the nation's economic operations. The market remained competitive because of rising production costs brought on by rising energy prices as well as increased domestic output to meet demands from both domestic and foreign markets. Later in December, as domestic merchants had sufficient stock, Acebutolol API prices began to decline. The policies being relaxed and the weak downstream demand influenced the market's ongoing decline. In December, the settlement price for Acebutolol API fell to USD 93590/MT FOB Shanghai.
Europe
- In the fourth quarter of 2022, prices for Acebutolol API showcased a soaring trajectory in the European region. The downstream market for the pharmaceutical sector was seen to have a steady demand for Acebutolol API. Price hikes were brought on by ongoing port congestion and supply disruption in the European region throughout Q4 022. Also, the European annual inflation rate was 10.6% in Q4 2022, up from 9.9%. Retailers in Europe make the decision to refill their inventory due to the approaching Christmas season considerably. Also, to ease the inflationary pressure, the market players were propelled to raise their quotations in order to slow down the demand and consumer consumption. The cost of Acebutolol API was USD 100270/MT CFR Hamburg toward the end of Q4 2022.
